Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
3.230
-0.350 (-9.78%)
Dec 26, 2025, 10:11 AM EST - Market open
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $5.73 million as of December 26, 2025. Its market cap has decreased by -58.47% in one year.
Market Cap
5.73M
Enterprise Value
15.68M
1-Year Change
-58.47%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $5.73M, a decrease of -97.51%. That is a compound annual growth rate of -47.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 6.35M | -52.97% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |